From SourceWatch
Jump to navigation Jump to search

Learn more about corporations VOTING to rewrite our laws.

Allergan is a specialist pharmaceutical company perhaps best known for Botox, used to treat facial wrinkles. Botox was originally used to treat muscle spasms, eye spasms and misalignment. The company's eye care products include medications for cataracts, glaucoma and pink eye, as well as eye and contact lens moisturizers. Allergen also makes products for acne and psoriasis.[1]

In the fiscal year ending of December of 2011, the company reported sales of approximately $5.3 billion dollars and had over 10,000 employees.[2]

Ties to the American Legislative Exchange Council

Allergan was the American Legislative Exchange Council (ALEC) State corporate co-chair of Tennessee,[3] a member of ALEC's Health and Human Services Task Force[4] and funder of ALEC's "scholarship fund."[5] In August 2011, Allergan was a "Chairman" level sponsor of the 38th Annual ALEC Conference[6] ($50,000 in 2010)[7] and a member of the Louisiana Host Committee.[8]

Allergan told Common Cause in May 2015 that it "is no longer an active member of ALEC."[9] Please see Corporations that Have Cut Ties to ALEC for more.

A list of ALEC corporations can be found here.

About ALEC
ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC's operations. They pay for a seat on ALEC task forces where corporate lobbyists and special interest reps vote with elected officials to approve “model” bills. Learn more at the Center for Media and Democracy's, and check out breaking news on our site.

Allergan Sells Generics Business to Teva Pharmaceutical for $40.5 Billion

In July 2015 Teva Pharmaceuticals Ltd., the largest drug company in Israel, announced that it would pay $40.5 billion to acquire Allergan's generic pharmaceuticals business. The deal included a $33.75 billion cash payment and $6.75 billion in Teva stock.[10]

Animal testing

Allergan does animal testing.

Violation Tracker
Discover Which Corporations are the Biggest Violators of Environmental, Health and Safety Laws in the United States
Violation Tracker is the first national search engine on corporate misconduct covering environmental, health, and safety cases initiated by 13 federal regulatory agencies. Violation Tracker is produced by the Corporate Research Project of Good Jobs First. Click here to access Violation Tracker.

Facility information, progress reports & USDA-APHIS reports

This facility performed animal experiments involving pain or distress but no analgesics, anesthetics or pain relievers were administered. For links to copies of this facility's U.S. Department of Agriculture-Animal Plant Health Inspection (APHIS) reports, other information and links, see also Facility Reports and Information: Allergan, Irvine, CA. [11]

USDA AWA reports

As of May 26, 2009, the USDA began posting all inspection reports for animal breeders, dealers, exhibitors, handlers, research facilities and animal carriers by state. See also USDA Animal Welfare Inspection Reports.


The Citizens Against Unfair Health Care Taxes is a front group created by a PR firm working for Allergan Inc., the maker of Botox. The group campaigned against a proposed California state tax on Botox. [12]

It describes itself as a group "that seeks to stop the unfair taxation of health care services and prescription drugs in various states.[13]

Political contributions

Allergan gave $202,762 to federal candidates in the 2010 election through its political action committee - 46% to Democrats and 54% to Republicans.[14]


The company spent $910,000 for lobbying in 2010. 844,000 went to outside firms with the remainder being spent using in-house lobbyists.[15]

Executives & board

Key executives [16]

  • David E.I. Pyott - President & CEO
  • David J. Endicott - Corporate Vice President: Allergan Medical, Asia Pacific and Latin America
  • Arnold A. Pinkston - Executive Vice President, General Counsel and Assistant Secretary
  • Raymond H. Diradoorian - Executive VP, Global Technical Operations
  • Jeff S. Gangoli - Corporate Vice President and President, North America
  • Jeffrey L. Edwards - Executive Vice President, Finance and Business Development, Chief Financial Officer
  • Douglas S. Ingram - Executive Vice President and President, Europe, Africa and Middle East
  • Scott M. Whitcup - Executive Vice President, Research and Development, Chief Scientific Officer
  • James F. Barlowe - Senior Vice President, Corporate Controller (Principal Accounting Officer)

Board of Directors:

  • David E.I. Pyott
  • Deborah Dunsire, M.D.
  • Russell T. Ray
  • Herbert W. Boyer, Ph.D.
  • Robert A. Ingram
  • Trevor M. Jones, Ph.D.
  • Dawn Hudson
  • Louis J. Lavigne, Jr.
  • Michael R. Gallagher
  • Stephen J. Ryan, M.D.

Former Executives

  • F. Michael Ball - Former President [17]

Board of Directors


2525 Dupont Drive
Irvine, CA 92612 USA

Phone: (714) 246-4500

Fax: (714) 246-6987

Web address:

Articles & sources

SourceWatch articles


  1. Company Profile: Allergan, Hoovers, accessed January 2011
  2. Allergan, Inc. Yearly Reports, Allergan, Published December 31st, 2012.
  3. American Legislative Exchange Council, "Solutions for the States," 38th Annual Meeting agenda, on file with CMD, August 3-6, 2011
  4. American Legislative Exchange Council, HHS Task Force, June 29, 2011, organizational membership spreadsheet, June 29, 2011, p. 32, obtained and released by Common Cause April 2012
  5. "Buying Influence: ALEC Scholarships by State," Center for Media and Democracy report, October 2012.
  6. American Legislative Exchange Council, 2011 Conference Sponsors, conference brochure on file with CMD, August 4, 2011
  7. American Legislative Exchange Council, Sponsorship Opportunities at ALEC's Annual Meeting, organizational website, 2010, accessed August 4, 2011
  8. American Legislative Exchange Council, "Solutions for the States," 38th Annual Meeting agenda, on file with CMD, August 3-6, 2011
  9. Jay Riestenberg, "Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer," Common Cause, May 14, 2015.
  10. Daniel Estrin, "Israel's Teva buys Allergan generic drug company for $40.5 billion," Associated Press, July 27, 2015.
  11. Facility Reports and Information: Allergan, Irvine, CA, Stop Animal Experimentation NOW!
  12. Andrew McIntosh Botox maker's lobbying assailed: 'Grass-roots' group fighting planned tax is company-created", Sacramento Bee, January 2006
  13. About the Coalition, Citizens Against Unfair Health Care Taxes, accessed December 2009
  14. 2010 PAC Summary Data, Open Secrets, accessed January 2011
  15. Allergan lobbying expenses, Open Secrets, accessed January 2011
  16. Allergan: Leadership Company website, Accessed April 19th, 2012
  17. 17.0 17.1 Board and Management, Allergan, accessed January 2008.